New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Aimovig erenumab-aooe Click here for more information |
Amgen | A calcitonin gene-related peptide receptor antagonist to prevent migraine. |
|
Akynzeo fosnetupitant/palonosetron Click here for more information |
Helsinn | An injectable formulation for prevention of chemo-induced nausea and vomiting. |
|
Andexxa coagulation factor Xa |
Portola Pharm | Anticoagulation reversal agent for rivaroxaban and apixaban. |
|
Biktarvy bictegravir/ emtricitabine/tenofovir alafenamide Click here for more information |
Gilead Sciences | A combination drug for treatment of HIV-1 infection. |
|
Braftovi encorafenib Click here for more information |
Array BioPharma | A kinase inhibitor for metastatic melanoma. |
|
Crysvita burosumab-twza Click here for more information |
Ultragenyx | A fibroblast growth factor 23 blocking antibody for X-linked hypophosphatemia. |
|
Doptelet avatrombopag Click here for more information |
Dova Pharm. | A thrombopoietin receptor agonist for thrombocytopenia in patients with chronic liver disease prior to undergoing a procedure. |
|
Epidiolex cannabidiol Click here for more information |
Greenwich Biosciences | A CBD oral solution for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. |
|
Erleada apalutamide Click here for more information |
Janssen | An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer. |
|
Fulphila pegfilgrastim-jmdb Click here for more information |
Mylan | The first biosimilar to Neulasta. |
|
Ilumya tildrakizumab-asmn Click here for more information |
Merck | An interleukin-23 antagonist for moderate-to-severe plaque psoriasis. |
|
Krintafel tafenoquine Click here for more information |
GSK | An antimalarial to prevent relapse of P. vivax infection. |
|
Lokelma sodium zirconium cyclosilicate Click here for more information |
AstraZeneca | A potassium binder for hyperkalemia. |
|
Lucemyra lofexidine Click here for more information |
US WorldMeds | An alpha-2 agonist to reduce opioid withdrawal symptoms. |
|
Lutathera lutetium Lu 177 dotatate Click here for more information |
Advanced Accelerator Applic. | A radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors. |
|
Mektovi binimetinib Click here for more information |
Array BioPharma | A kinase inhibitor for metastatic melanoma. |
|
Moxidectin moxidectin Click here for more information |
Medicines Devlopment | An anthelmintic for onchocerciasis. |
|
Mulpleta lusutrombopag Click here for more information |
Shionogi | A thrombopoietin receptor agonist for use in chronic liver disease patients to treat thrombocytopenia prior to undergoing a procedure. |
|
Olumiant baricitinib Click here for more information |
Lilly | An oral Janus kinase inhibitor for rheumatoid arthritis. |
|
Omegaven fish oil triglycerides Click here for more information |
Fresenius Kabi | An injectable source of calories/fatty acids for pediatric patients with parenteral nutrition-associated cholestasis. |
|
Orilissa elagolix Click here for more information |
AbbVie | A gonadotropin-releasing hormone receptor antagonist for pain associated with endometriosis. |
|
Palynziq pegvaliase-pqpz Click here for more information |
BioMarin Pharm. | An enzyme to reduce blood phenylalanine levels in patients with phenylketonuria. |
|
Poteligeo mogamulizumab-kpkc Click here for more information |
Kyowa Kirin | A monoclonal antibody for advanced mycosis fungoides or Sézary syndrome. |
|
Retacrit epoetin alfa-epbx Click here for more information |
Hospira | A biosimilar to Epogen/Procrit. |
|
Symdeko tezacaftor/ivacaftor Click here for more information |
Vertex Pharm. | A combination formulation for cystic fibrosis in patients with a specific gene mutation. |
|
Tavalisse fostamatinib Click here for more information |
Rigel Pharm. | A kinase inhibitor for chronic immune thrombocytopenia. |
|
Tibsovo ivosidenib Click here for more information |
Agios Pharm. | An IDH1 inhibitor for advanced acute myeloid leukemia. |
|
Tpoxx tecovirimat Click here for more information |
Siga Technologies | A new drug for the treatment of human smallpox disease. |
|
Trogarzo ibalizumab-uiyk Click here for more information |
Thera Technologies | An antiretroviral for patients with multidrug resistant HIV-1 infection. |
|
Zemdri plazomicin Click here for more information |
Achaogen | An aminoglycoside antibiotic for complicated UTI including pyelonephritis. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Apadaz benzhydrocodone/acetaminophen Click here for more information |
KemPharm | New combination formulation for short-term management of acute pain. |
|
Arakoda tafenoquine Click here for more information |
60 Degrees Pharm. | A lower dose formulation for prophylaxis of malaria. |
|
Aristada Initio aripiprazole Click here for more information |
Alkermes | New single-dose pre-filled syringe for use when initiating treatment with Aristada. |
|
Cimduo lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. |
|
Consensi amlodipine/celecoxib Click here for more information |
Kitov Pharma | New CCB/NSAID combination formulation for patients with hypertension and osteoarthritis. |
|
Dexycu dexamethasone Click here for more information |
Icon Bioscience | New intraocular suspension formulation for postoperative inflammation. |
|
Firvanq vancomycin |
CurtisPharma | An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA). |
|
Imvexxy estradiol Click here for more information |
TherapeuticsMD | New vaginal insert estrogen formulation for dyspareunia due to menopause. |
|
Jynarque tolvaptan |
Otsuka America | New formulation of tolvaptan to slow kidney function decline in patients at risk of progressing autosomal dominant polycystic kidney disease. |
|
Nocdurna desmopressin Click here for more information |
Ferring | New sublingual tablet formulation for nocturia. |
|
Osmolex ER amantadine Click here for more information |
Vertical Pharm. | New extended-release tablet formulation. |
|
Perseris risperidone Click here for more information |
Indivior | New extended-release injectable formulation for subcutaneous administration. |
|
Plenvu PEG 3350 plus electrolytes Click here for more information |
Norgine | A lower-volume, 1-liter bowel prep for colonoscopies. |
|
Qbrexza glycopyrronium |
Dermira | An anticholinergic topical treatment for axillary hyperhidrosis. |
|
Symfi efavirenz/lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. Contains a higher strength of efavirenz/tablet vs Symfi Lo. |
|
Symfi Lo efavirenz/lamivudine/tenofovir disoproxil fumarate Click here for more information |
Mylan | New combination formulation for HIV-1 infection. |
|
Symtuza darunavir/cobicistat/emtricitabine/tenofovir alafenamide Click here for more information |
Janssen | New combination formulation for HIV-1 infection. |
|
Yonsa abiraterone Click here for more information |
Sun Pharm. | New lower strength formulation for metastatic castration-resistant prostate cancer. |
|
Ztlido lidocaine Click here for more information |
Scilex Pharm. | New topical patch formulation for post-herpetic neuralgia pain. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Zinbryta Daclizumab Click here for more information |
Biogen/AbbVie | The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions. |